| RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: Oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation M Wada, Y Goto, T Tanaka, R Okada, S Moriya, T Idichi, M Noda, ... Journal of human genetics 65 (11), 1019-1034, 2020 | 39 | 2020 |
| Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma R Okada, K Koshizuka, Y Yamada, S Moriya, N Kikkawa, T Kinoshita, ... Cells 8 (12), 1535, 2019 | 37 | 2019 |
| Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes T Tanaka, R Okada, Y Hozaka, M Wada, S Moriya, S Satake, T Idichi, ... Cancers 12 (10), 2731, 2020 | 27 | 2020 |
| Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer K Kawagoe, M Wada, T Idichi, R Okada, Y Yamada, S Moriya, K Okubo, ... Journal of Human Genetics 65 (8), 647-656, 2020 | 24 | 2020 |
| Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes Y Shinden, T Hirashima, N Nohata, H Toda, R Okada, S Asai, T Tanaka, ... Journal of Human Genetics 66 (5), 519-534, 2021 | 20 | 2021 |
| FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p) K Mizuno, K Tanigawa, N Nohata, S Misono, R Okada, S Asai, S Moriya, ... Cells 9 (9), 2083, 2020 | 19 | 2020 |
| Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target S Misono, K Mizuno, T Suetsugu, K Tanigawa, N Nohata, A Uchida, ... Cancers 13 (6), 1187, 2021 | 16 | 2021 |
| Role of miR-30a-3p regulation of oncogenic targets in pancreatic ductal adenocarcinoma pathogenesis H Shimomura, R Okada, T Tanaka, Y Hozaka, M Wada, S Moriya, T Idichi, ... International Journal of Molecular Sciences 21 (18), 6459, 2020 | 16 | 2020 |
| Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner T Aoki, M Takami, T Takatani, K Motoyoshi, A Ishii, A Hara, T Toyoda, ... Cancer Science 111 (7), 2223-2233, 2020 | 16 | 2020 |
| Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma R Okada, Y Goto, Y Yamada, M Kato, S Asai, S Moriya, T Ichikawa, N Seki Biomedicines 8 (12), 599, 2020 | 15 | 2020 |
| Application of self-compacting concrete made with low-heat cement for bridge substructures of Honshu-Shikoku Bridge Authority S Kashima, K Kanazawa, R Okada, S Yoshikawa Proceedings of the International Workshop on Self-Compacting Concrete, 255-261, 1999 | 15 | 1999 |
| Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma M Sun, Y Cao, R Okada, JM Reyes-González, HG Stack, H Qin, N Li, ... Journal for ImmunoTherapy of Cancer 11 (1), 2023 | 10 | 2023 |
| Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy R Nguyen, E Doubrovina, CM Mousset, BY Jin, R Okada, X Zhang, ... Clinical Cancer Research 30 (8), 1555-1566, 2024 | 2 | 2024 |
| Invariant NKT cells recognize leukemia cells with T-cell and NK receptors in a CD1d-independent manner T Aoki, M Takami, T Takatani, K Motoyoshi, A Ishii, A Hara, T Toyoda, ... Blood 134, 3225, 2019 | 2 | 2019 |
| Monitoring and analysis of seabed-layer deformation at the Akashi kaikyo Bridge Tower Foundation M YAMAGATA, R OKADA, S NASU, M ABE Tsuchi to kiso 41 (2), 33-36, 1993 | 1 | 1993 |
| Targeting DLK1, a Notch ligand, with an antibody-drug conjugate in adrenocortical carcinoma NY Sun, S Kumar, A Weiner, YS Kim, A Mendoza, R Nguyen, R Okada, ... Cancer Research 84 (6_Supplement), 6573-6573, 2024 | | 2024 |
| Science and Medical Communication on Social Networking Services by COV-Navi, a Health Communication Project for COVID-19 Vaccines M SOMIYA, R OKADA, T KINOSHITA, K YASUKAWA 科学技術コミュニケーション (Web), 29-38, 2022 | | 2022 |
| Regulation of oncogenic targets by miR-99a-3p (the passenger strand of the miR-99a-duplex) in head and neck squamous cell carcinoma R Okada, K Koshizuka, Y Yamada, S Moriya, N Kikkawa, T Kinoshita, ... Cancer Research 80 (16_Supplement), 3711-3711, 2020 | | 2020 |
| An Experience of Human Bone Marrow-Derived Mesenchymal Stem Cells Therapy for Steroid-Refractory GVHD Y Yamashita, M Hino, R Okada, N Simojou PEDIATRIC BLOOD & CANCER 66, S123-S124, 2019 | | 2019 |
| Clinical Courses and Susceptibility of Pathogenic Fungi Identified from Pediatric Oncology Patients: Single Center Experience M Hino, N Ishiwada, T Aoki, R Okada, T Okunushi, M Okusu, A Watanabe, ... PEDIATRIC BLOOD & CANCER 65, S511-S512, 2018 | | 2018 |
